---
title: "Mega Genomics Limited (06667.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/06667.HK.md"
symbol: "06667.HK"
name: "Mega Genomics Limited"
industry: "Health Care Services"
---

# Mega Genomics Limited (06667.HK)

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Location | HK Market |
| Website | [www.megagenomics.cn](https://www.megagenomics.cn) |

## Company Profile

Mega Genomics Limited, a genetic testing platform company, provides consumer genetic testing and cancer screening services in China. It offers general testing services, including brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer’s dise...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-19T04:30:12.000Z

**Overall: C (0.52)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 8 / 29 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -13.33% |  |
| Net Profit YoY | 10.98% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.41 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.61B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 149.87M |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 5.55% | C |
| Profit Margin | 25.57% | A |
| Gross Margin | 73.99% | A |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -13.33% | E |
| Net Profit YoY | 10.98% | C |
| Total Assets YoY | -15.77% | E |
| Net Assets YoY | -5.98% | D |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 391.14% | C |
| OCF YoY | -13.33% | E |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.18 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 11.11% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Mega Genomics Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "5.55%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "25.57%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "73.99%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-13.33%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "10.98%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-15.77%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-5.98%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "391.14%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-13.33%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.18",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "11.11%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | GUSHENGTANG (HK.2273) | B | B | B | B | B | B |
| 02 | HUMAN HEALTH (HK.1419) | C | C | B | B | B | B |
| 03 | UNI MEDICAL (HK.2666) | B | C | D | D | B | C |
| 04 | HEALTHYWAY INC (HK.2587) | B | C | A | D | E | C |
| 05 | DISTINCT HEALTH (HK.2677) | D | A | B | E | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 41.68 | 10/29 | 46.22 | 46.22 | 46.22 |
| PB | 2.41 | 21/29 | 2.22 | 2.22 | 2.22 |
| PS (TTM) | 10.66 | 29/29 | 9.23 | 9.23 | 9.23 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2022-12-29T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 7.20 |

## References

- [Company Overview](https://longbridge.com/en/quote/06667.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/06667.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/06667.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.